Combined loss of M2 and M3 muscarinic acetylcholine receptor (mAChR) function in mutant mice increases serotonin airway responsiveness (AR) Source: International Congress 2014 – Animal models in respiratory drug development Year: 2014
Involvement of NK1, 2 and 3 receptors on antigen-induced airway hyperresponsiveness and inflammation induced in guinea-pigs Source: Eur Respir J 2001; 18: Suppl. 33, 246s Year: 2001
Effect of AVE5883, a dual NK1/NK2 receptor antagonist, on airway responsiveness to neurokinin A in asthma Source: Eur Respir J 2004; 24: Suppl. 48, 219s Year: 2004
Cholinergic muscarinic receptors and airway remodelling in severe asthma Source: International Congress 2018 – Studies on the mechanisms underlying airway disease Year: 2018
The muscarinic M3 receptor regulates allergen-induced airway remodeling in mice Source: Annual Congress 2013 –Asthma drugs: new findings Year: 2013
Antigen-induced airway hyperresponsiveness and eosinophilia in mice is inhibited by the endothelin receptor antagonist SB217242 Source: Eur Respir J 2001; 18: Suppl. 33, 349s Year: 2001
Increased relaxation of immature airways to beta-2 agonists is related to the attenuated expression of postjunctional smooth muscle muscarinic M2 receptors Source: Annual Congress 2004 - Understanding the complexity of how airways are regulated Year: 2004
Role of muscarinic receptors in airway inflammation and remodelling Source: International Congress 2015 – Respiratory research in the Netherlands Year: 2015
Modulatory role of tachykinin NK1 receptor in cholinergic contraction of mouse trachea Source: Eur Respir J 2003; 21: 3-10 Year: 2003
Insulin acutely potentiates M3 muscarinic receptor function in rat and human airway smooth muscle Source: International Congress 2017 – Therapeutic approaches in lung disease Year: 2017
Expression of the cysteinyl leukotriene receptors cysLT1 and cysLT2 in the airway structural cells Source: Eur Respir J 2005; 26: Suppl. 49, 346s Year: 2005
EP2 & EP4 receptor agonists inhibit the airway sensory nerves that cause cough, a potential protective control that is lost in human smokers and a pre-clinical COPD model Source: International Congress 2017 – Novel mechanisms and treatments for COPD Year: 2017
Requirement for the p75 TNF-α receptor 2 in the regulation of airway hyperresponsiveness byγδ T Cells Source: Annual Congress 2003 - Models of immune responses and airway disease Year: 2003
Comparison of glucocorticoid and cysteinyl leukotriene receptor antagonist treatments in the airway remodeling induced by chronic airway inflammation in guinea pigs Source: Annual Congress 2008 - Novel experimental approaches to understanding asthma and COPD II Year: 2008
Expression and functional involvement of muscarinic receptor 3 (M3) in human lung fibroblasts in COPD Source: Eur Respir J 2005; 26: Suppl. 49, 121s Year: 2005
Airway responsiveness to beta-adrenergic agonist in smokers Source: Eur Respir J 2004; 24: Suppl. 48, 341s Year: 2004
Effects of a newly developed dual CysLT1 and CysLT2 receptor antagonist, ONO-RS-531, on antigen- and leukotriene D4 -induced contractions of isolated human bronchi Source: Eur Respir J 2005; 26: Suppl. 49, 214s Year: 2005
Potentiation effect of insulin on M3 muscarinic receptor agonist induced airway smooth muscle contraction Source: International Congress 2019 – Airway inflammation: pharmacological mechanisms and novel targets Year: 2019
Increased airway responsiveness to beta-adrenergic agonists in asthmatic patients Source: Eur Respir J 2005; 26: Suppl. 49, 582s Year: 2005
Involvement of neuropeptide and muscarinic receptor in pulmonary obstruction induced by cigarette smoke in mice Source: Eur Respir J 2004; 24: Suppl. 48, 691s Year: 2004